Defib Data Will Provide Different Opportunities For Medtronic, CMS
This article was originally published in The Gray Sheet
Executive Summary
Medtronic appears intent to use data collected from ongoing studies and patient registries on cardiac resynchronization therapies to shift the heart failure treatment paradigm from drugs toward devices